MedTrace Logo

Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)

NCT04128449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-10-18

No results posted yet for this study

Summary

In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the performance improvement was determined after the consumption of docosahexaenoic acid for one month.

Conditions

  • Performance

Interventions

DIETARY_SUPPLEMENT

docosahexaenoic acid

5 dragees every 24 hours

DIETARY_SUPPLEMENT

Placebo

5 dragees every 24 hours

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04128449 on ClinicalTrials.gov